These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3054003)

  • 41. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
    Boussiotis VA; Pangalis GA
    Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low doses of alpha 2B interferon in the treatment of hairy cell leukemia: results of treatment and mean follow-up at 18 months in 13 patients.
    Santagati G; Nastasi G; Porta C; Moroni M; Santagati C; Casagranda I; Bobbio-Pallavicini E; Cosimi MF
    Pathologica; 1994 Feb; 86(1):66-9. PubMed ID: 8072805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.
    Liberati AM; Fizzotti M; Di Clemente F; Senatore M; Berruto P; Falini B; Martelli MF; Grignani F
    Leuk Res; 1990; 14(9):779-84. PubMed ID: 2232850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
    Hill M; Norman A; Cunningham D; Findlay M; Nicolson V; Hill A; Iveson A; Evans C; Joffe J; Nicolson M
    J Clin Oncol; 1995 Jun; 13(6):1297-302. PubMed ID: 7751874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
    Mitchell MS; Abrams J; Thompson JA; Kashani-Sabet M; DeConti RC; Hwu WJ; Atkins MB; Whitman E; Ernstoff MS; Haluska FG; Jakowatz JG; Das Gupta TK; Richards JM; Samlowski WE; Costanzi JJ; Aronson FR; Deisseroth AB; Dudek AZ; Jones VE
    J Clin Oncol; 2007 May; 25(15):2078-85. PubMed ID: 17513813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia.
    Federico M; Chisesi T; Lauria F; Bernasconi C; Capnist G; Castoldi G; Damasio E; Pagnucco G; Frassoldati A; Resegotti L
    Br J Haematol; 1989 May; 72(1):54-6. PubMed ID: 2660901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.
    Minasian LM; Motzer RJ; Gluck L; Mazumdar M; Vlamis V; Krown SE
    J Clin Oncol; 1993 Jul; 11(7):1368-75. PubMed ID: 8315435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
    Quesada JR; Lepe-Zuniga JL; Gutterman JU
    Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study.
    Thompson JA; Fefer A
    Invest New Drugs; 1987; 5 Suppl():S5-8. PubMed ID: 3298134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
    Holmes R; Schwarz MA; Whiteside MG; Firkin FC
    Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of hairy cell leukemia: long-term results in a developing country.
    Ruiz-Delgado GJ; Tarín-Arzaga LC; Alarcón-Urdaneta C; Calderón-García J; Gómez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2012 May; 17(3):140-3. PubMed ID: 22664112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of hairy cell leukaemia with recombinant alpha interferon.
    Romeril KR; Carter JM; Green GJ; Beard ME; Heaton DC; Newhook CH; Gibbons SS; Reddy J
    N Z Med J; 1989 Apr; 102(866):186-8. PubMed ID: 2652008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
    Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H;
    Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hairy-cell leukemia (a review of the literature and the authors' own data)].
    Volkova MA; Lepkov SV; Frenkel' MA; Lebedeva NB; Tupitsyn NN
    Ter Arkh; 1994; 66(7):43-9. PubMed ID: 7985128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
    Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
    N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained long-term remissions with weekly interferon maintenance therapy in hairy cell leukemia.
    Ramakrishna R; Manoharan A
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):210-2. PubMed ID: 20887503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.